ResearcherMedical University of ViennaActive in the last 2 years

Sandra Stickler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-7528-5525; OpenAlex author ID A5046265653. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Targeting KRAS in pancreatic cancer. Co-author DOI 10.32604/or.2024.045356 ↗
Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines. Co-author DOI 10.1007/s12672-022-00550-w ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gerhard Hamilton · 2 shared papers, 2022–2024 · strength 0.53
- Paper Targeting KRAS in pancreatic cancer. DOI 10.32604/or.2024.045356 ↗
- Paper Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines. DOI 10.1007/s12672-022-00550-w ↗
Adelina Plangger · 1 shared paper, 2022 · strength 0.16
- Paper Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines. DOI 10.1007/s12672-022-00550-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.